Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial

BACKGROUND: Chronic kidney disease is a common disease. Most chronic kidney diseases evolve from primary glomerulonephritis. Proteinuria is an independent risk factor for the progression of chronic kidney disease. The general consensus is that therapy administered to decrease proteinuria should incl...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Trials
Main Authors: Kou, Jia, Wu, Jie, Yang, Hong-tao, He, Ya-ni, Fang, Jing-ai, Deng, Yue-yi, Xie, Yuan-sheng, Nie, Li-fang, Lin, Hong-li, Cai, Guang-yan, Chen, Xiang-mei
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Study Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289030/
https://ncbi.nlm.nih.gov/pubmed/25480673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-479
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki